0002084032
Company

Salspera, Inc.

Pharmaceutical Preparations · TKVA

ipo amended Nasdaq S-1/A

Filing Timeline

SEC EDGAR
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2026-03-20 · 0001213900-26-032383
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2026-03-10 · 0001213900-26-025748
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
First tracked pre-IPO filing for this issuer.
2026-03-04 · 0001213900-26-023531
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2026-02-23 · 0001213900-26-019404
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
2026-02-02 · 0001213900-26-010732
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
2025-12-29 · 0001213900-25-126099
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2025-09-12 · 0001213900-25-087303

Recent News

No recent news stored for this issuer.